| The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19 FA Klok, GJAM Boon, S Barco, M Endres, JJM Geelhoed, S Knauss, ... European Respiratory Journal 56 (1), 2020 | 611 | 2020 |
| Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study RT Urbanus, B Siegerink, M Roest, FR Rosendaal, PG de Groot, A Algra The Lancet Neurology 8 (11), 998-1005, 2009 | 518 | 2009 |
| Graphical presentation of confounding in directed acyclic graphs MM Suttorp, B Siegerink, KJ Jager, C Zoccali, FW Dekker Nephrology Dialysis Transplantation 30 (9), 1418-1423, 2015 | 244 | 2015 |
| Contribution of established stroke risk factors to the burden of stroke in young adults A Aigner, U Grittner, A Rolfs, B Norrving, B Siegerink, MA Busch Stroke 48 (7), 1744-1751, 2017 | 240 | 2017 |
| A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study D Munblit, T Nicholson, A Akrami, C Apfelbacher, J Chen, W De Groote, ... The Lancet Respiratory Medicine 10 (7), 715-724, 2022 | 193* | 2022 |
| High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women HM Andersson, B Siegerink, BM Luken, JTB Crawley, A Algra, DA Lane, ... Blood, The Journal of the American Society of Hematology 119 (6), 1555-1560, 2012 | 187 | 2012 |
| Association between dispatch of mobile stroke units and functional outcomes among patients with acute ischemic stroke in Berlin M Ebinger, B Siegerink, A Kunz, M Wendt, JE Weber, E Schwabauer, ... Jama 325 (5), 454-466, 2021 | 180* | 2021 |
| Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis AH Nave, KS Lange, CO Leonards, B Siegerink, W Doehner, ... Atherosclerosis 242 (2), 496-503, 2015 | 175 | 2015 |
| Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? CE Jacobi, GH de Bock, B Siegerink, CJ van Asperen Breast cancer research and treatment 115, 381-390, 2009 | 147 | 2009 |
| Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19 FVC Machado, R Meys, JM Delbressine, AW Vaes, YMJ Goërtz, ... Health and quality of life outcomes 19, 1-10, 2021 | 146 | 2021 |
| Intrinsic Coagulation Activation and the Risk of Arterial Thrombosis in Young Women; Results From the Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO … B Siegerink, JWP Govers-Riemslag, FR Rosendaal, H Ten Cate, A Algra Circulation 122 (18), 1854-1861, 2010 | 130 | 2010 |
| Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke B Siegerink, FR Rosendaal, A Algra Journal of thrombosis and haemostasis 7 (3), 385-390, 2009 | 124 | 2009 |
| Where have all the rodents gone? The effects of attrition in experimental research on cancer and stroke C Holman, SK Piper, U Grittner, AA Diamantaras, J Kimmelman, ... PLoS biology 14 (1), e1002331, 2016 | 117 | 2016 |
| Association of high body mass index with decreased treatment response to combination therapy in recent‐onset rheumatoid arthritis patients L Heimans, M Van Den Broek, S le Cessie, B Siegerink, N Riyazi, KH Han, ... Arthritis care & research 65 (8), 1235-1242, 2013 | 107 | 2013 |
| Mendelian randomization: use of genetics to enable causal inference in observational studies M Verduijn, B Siegerink, KJ Jager, C Zoccali, FW Dekker Nephrology dialysis transplantation 25 (5), 1394-1398, 2010 | 100 | 2010 |
| Role of obesity in the etiology of deep vein thrombosis and pulmonary embolism: current epidemiological insights SK Braekkan, B Siegerink, WM Lijfering, JB Hansen, SC Cannegieter, ... Seminars in thrombosis and hemostasis 39 (05), 533-540, 2013 | 77 | 2013 |
| Thrombo-inflammation in cardiovascular disease: an expert consensus document from the Third Maastricht Consensus Conference on Thrombosis E d’Alessandro, C Becker, W Bergmeier, C Bode, JH Bourne, H Brown, ... Thrombosis and haemostasis 120 (04), 538-564, 2020 | 76 | 2020 |
| Plasma ADAMTS‐13 levels and the risk of myocardial infarction: an individual patient data meta‐analysis A Maino, B Siegerink, LA Lotta, JTB Crawley, S le Cessie, FWG Leebeek, ... Journal of Thrombosis and Haemostasis 13 (8), 1396-1404, 2015 | 71 | 2015 |
| Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up … B Siegerink, R Maas, CY Vossen, E Schwedhelm, W Koenig, R Böger, ... Clinical Research in Cardiology 102, 193-202, 2013 | 71 | 2013 |
| Hypercoagulability is a stronger risk factor for ischaemic stroke than for myocardial infarction: a systematic review A Maino, FR Rosendaal, A Algra, F Peyvandi, B Siegerink PloS one 10 (8), e0133523, 2015 | 63 | 2015 |
Frits Rosendaalhoogleraar Klinische Epidemiologie, Leiden University Medical CenterVerified email at lumc.nl
